Jillian Kutch Pierorazio

Array ( [id] => 3408457 [patent_doc_number] => 05443754 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-22 [patent_title] => 'Pyridylpyrimidines, a process for their preparation and their use in liquid-crystalline mixtures' [patent_app_type] => 1 [patent_app_number] => 8/064024 [patent_app_country] => US [patent_app_date] => 1993-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5566 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 585 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/443/05443754.pdf [firstpage_image] =>[orig_patent_app_number] => 064024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3116064 [patent_doc_number] => 05449682 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-12 [patent_title] => 'Angiotensin II antagonists incorporating a substituted benzyl element' [patent_app_type] => 1 [patent_app_number] => 8/061975 [patent_app_country] => US [patent_app_date] => 1993-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75334 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 2284 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/449/05449682.pdf [firstpage_image] =>[orig_patent_app_number] => 061975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3037821 [patent_doc_number] => 05373012 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-13 [patent_title] => '5-fluoro-2,4,6-pyrimidinetriamine compounds' [patent_app_type] => 1 [patent_app_number] => 8/059552 [patent_app_country] => US [patent_app_date] => 1993-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4512 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/373/05373012.pdf [firstpage_image] =>[orig_patent_app_number] => 059552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3056028 [patent_doc_number] => 05356922 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-18 [patent_title] => 'Imidazole compounds, processes for their preparation, pharmaceuticals based on these compounds and some intermediates' [patent_app_type] => 1 [patent_app_number] => 8/057887 [patent_app_country] => US [patent_app_date] => 1993-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11993 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/356/05356922.pdf [firstpage_image] =>[orig_patent_app_number] => 057887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3413122 [patent_doc_number] => 05444062 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-22 [patent_title] => 'Quinazolines derivatives for enhancing antitumor activity' [patent_app_type] => 1 [patent_app_number] => 8/050047 [patent_app_country] => US [patent_app_date] => 1993-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17963 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1308 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/444/05444062.pdf [firstpage_image] =>[orig_patent_app_number] => 050047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3420233 [patent_doc_number] => 05478832 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-26 [patent_title] => 'Quinoline compounds' [patent_app_type] => 1 [patent_app_number] => 8/055873 [patent_app_country] => US [patent_app_date] => 1993-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12608 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 319 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/478/05478832.pdf [firstpage_image] =>[orig_patent_app_number] => 055873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2994134 [patent_doc_number] => 05366955 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-22 [patent_title] => 'Pyrimidone derivatives and their use' [patent_app_type] => 1 [patent_app_number] => 8/053399 [patent_app_country] => US [patent_app_date] => 1993-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13095 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/366/05366955.pdf [firstpage_image] =>[orig_patent_app_number] => 053399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3010434 [patent_doc_number] => 05281603 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-01-25 [patent_title] => 'Angiotensin II receptor blocking 2,3,6 substituted quinazolinones' [patent_app_type] => 1 [patent_app_number] => 8/052934 [patent_app_country] => US [patent_app_date] => 1993-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5381 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 252 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/281/05281603.pdf [firstpage_image] =>[orig_patent_app_number] => 052934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3018893 [patent_doc_number] => 05288720 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-22 [patent_title] => 'Angiotensin II receptor blocking 2,3,6 substituted quinazolinones' [patent_app_type] => 1 [patent_app_number] => 8/052940 [patent_app_country] => US [patent_app_date] => 1993-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17700 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/288/05288720.pdf [firstpage_image] =>[orig_patent_app_number] => 052940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3066002 [patent_doc_number] => 05294617 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-03-15 [patent_title] => 'Angiotensin II receptor blocking 2,3,6 substituted quinazolinones' [patent_app_type] => 1 [patent_app_number] => 8/052932 [patent_app_country] => US [patent_app_date] => 1993-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6852 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 795 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/294/05294617.pdf [firstpage_image] =>[orig_patent_app_number] => 052932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3010452 [patent_doc_number] => 05281604 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-01-25 [patent_title] => 'Angiotensin II receptor blocking 2,3,6-substituted quinazolinones' [patent_app_type] => 1 [patent_app_number] => 8/052944 [patent_app_country] => US [patent_app_date] => 1993-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6641 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/281/05281604.pdf [firstpage_image] =>[orig_patent_app_number] => 052944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2997749 [patent_doc_number] => 05358951 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-25 [patent_title] => 'Angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones' [patent_app_type] => 1 [patent_app_number] => 8/052945 [patent_app_country] => US [patent_app_date] => 1993-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26640 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1005 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/358/05358951.pdf [firstpage_image] =>[orig_patent_app_number] => 052945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3014628 [patent_doc_number] => 05332807 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-07-26 [patent_title] => 'Process of producing 8A- and 9A-azalide antibiotics' [patent_app_type] => 1 [patent_app_number] => 8/048048 [patent_app_country] => US [patent_app_date] => 1993-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25314 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/332/05332807.pdf [firstpage_image] =>[orig_patent_app_number] => 048048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3125830 [patent_doc_number] => 05436338 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-25 [patent_title] => 'Heterocyclic formamidines useful as ultraviolet light absorbers' [patent_app_type] => 1 [patent_app_number] => 8/045571 [patent_app_country] => US [patent_app_date] => 1993-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2396 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/436/05436338.pdf [firstpage_image] =>[orig_patent_app_number] => 045571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3478932 [patent_doc_number] => 05399557 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-21 [patent_title] => 'Pyrroloazepine compound' [patent_app_type] => 1 [patent_app_number] => 8/030427 [patent_app_country] => US [patent_app_date] => 1993-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14305 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/399/05399557.pdf [firstpage_image] =>[orig_patent_app_number] => 030427 [rel_patent_id] =>[rel_patent_doc_number] =>)